Report cover image

Bioabsorbable Stents Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032

Published Mar 12, 2026
Length 197 Pages
SKU # PERR21001494

Description

Persistence Market Research has recently released a comprehensive report on the global Bioabsorbable Stents Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:
  • Bioabsorbable Stents Market Size (2025E): US$ 0.53 Bn
  • Projected Market Value (2032F): US$ 1.1 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 10.2%
Bioabsorbable Stents Market - Report Scope:

The bioabsorbable stents market focuses on advanced medical devices designed to temporarily support blocked or narrowed arteries and gradually dissolve in the body over time. Unlike traditional metallic stents that remain permanently implanted, bioabsorbable stents are engineered from materials such as polymers and bioresorbable metals that naturally degrade after restoring blood flow. These stents are widely used in the treatment of coronary artery disease and peripheral artery disease. Growing technological advancements in interventional cardiology, rising preference for minimally invasive procedures, and increasing research and development in biodegradable medical devices are contributing to the growth of the global bioabsorbable stents market.

Market Growth Drivers:

The growth of the global bioabsorbable stents market is primarily driven by the increasing prevalence of cardiovascular diseases worldwide, which has significantly raised the demand for advanced interventional treatments. Rising adoption of minimally invasive procedures among patients and healthcare providers is also accelerating the use of bioabsorbable stents, as these devices offer reduced recovery time and fewer complications compared to traditional surgical procedures. Additionally, the growing adoption of next-generation stent technologies that naturally dissolve within the body helps minimize long-term complications such as in-stent restenosis and thrombosis. Continuous advancements in biomaterials, increasing healthcare expenditure, and expanding access to advanced cardiology treatments further support market growth.

Market Restraints:

Despite promising growth prospects, the bioabsorbable stents market faces certain challenges that may hinder its expansion. One of the primary restraints is the high cost associated with bioabsorbable stent technologies compared to conventional metallic stents, which can limit their adoption in price-sensitive healthcare systems. In addition, concerns related to clinical performance, such as delayed absorption rates and potential complications in certain patient groups, may affect physician confidence and slow market penetration. Regulatory challenges and lengthy approval processes for innovative cardiovascular devices also present barriers for manufacturers seeking to introduce new products into global markets.

Market Opportunities:

The bioabsorbable stents market presents significant opportunities driven by ongoing innovations in biodegradable materials and cardiovascular device engineering. Increasing investment in research and development aimed at improving stent strength, flexibility, and controlled degradation rates is expected to create new product advancements in the coming years. Emerging economies in Asia-Pacific, Latin America, and the Middle East are also providing lucrative opportunities due to improving healthcare infrastructure, growing awareness of advanced cardiac treatments, and rising patient populations suffering from cardiovascular diseases. Furthermore, strategic collaborations between medical device manufacturers, research institutions, and healthcare providers can accelerate product innovation and expand market presence globally.

Key Questions Answered in the Report:
  • What are the primary factors driving the global bioabsorbable stents market's growth?
  • Which regions and market segments are experiencing the highest demand for bioabsorbable stents?
  • How are technological advancements in biodegradable medical devices influencing market development?
  • Who are the key players in the bioabsorbable stents market, and what strategies are they adopting to maintain competitiveness?
  • What are the emerging trends and long-term projections for the global bioabsorbable stents market?
Competitive Intelligence and Business Strategy:

Leading companies operating in the global bioabsorbable stents market are focusing on innovation, clinical research, and strategic collaborations to strengthen their market position. Manufacturers are investing heavily in the development of next-generation bioresorbable materials and drug-eluting technologies to enhance device performance and safety. Partnerships with hospitals, cardiology centers, and research institutions are helping companies accelerate clinical trials and regulatory approvals. In addition, companies are expanding their global distribution networks and entering emerging markets to increase product accessibility and improve their competitive presence in the rapidly evolving cardiovascular device market.

Companies Covered in This Report:
  • Biotronik SE & Co. KG
  • Elixir Medical Corporation
  • Abbott Laboratories
  • REVA Medical, LLC
  • Arterius Ltd.
  • Boston Scientific Corporation
  • Lepu Medical Technology Co., Ltd.
  • Terumo Corporation
  • Amaranth Medical
  • S3V Vascular Technologies
  • Kyoto Medical Planning Co., Ltd.
  • MicroPort Scientific Corporation
  • Zorion Medical
  • SMT (Sahajanand Medical Technologies)
  • Hexacath
  • Cardionovum GmbH
  • B. Braun Melsungen AG
Market Segmentation

By Material Type
  • Polymer-based Bioabsorbable Stents
  • Metal-based Bioabsorbable Stents
By Product Type
  • Drug-eluting Bioabsorbable Stents
  • Bare Bioabsorbable Stents
By Application
  • Coronary Artery Disease (CAD)
  • Peripheral Artery Disease (PAD)
By End-use
  • Hospitals
  • Cardiology Centers
  • Ambulatory Surgical Centers (ASCs)
  • Specialty Clinics
By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • South Asia & Oceania
  • Middle East & Africa


Please Note: It will take 5 business days to complete the report upon order confirmation.

Table of Contents

197 Pages
1. Executive Summary
1.1. Global Bioabsorbable Stents Market Snapshot, 2025 And 2032
1.2. Market Opportunity Assessment, 2025-2032, Us$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments And Key Market Events
1.7. Pmr Analysis And Recommendations
2. Market Overview
2.1. Market Scope And Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Key Trends
2.3. Macro-economic Factors
2.3.1. Global Sectoral Outlook
2.3.2. Global Gdp Growth Outlook
2.4. Covid-19 Impact Analysis
2.5. Forecast Factors - Relevance And Impact
3. Value Added Insights
3.1. Tool Adoption Analysis
3.2. Regulatory Landscape
3.3. Value Chain Analysis
3.4. Pestle Analysis
3.5. Porter’s Five Force Analysis
4. Price Analysis, 2024a
4.1. Key Highlights
4.2. Key Factors Impacting Deployment Costs
4.3. Pricing Analysis, By Component Type
5. Global Bioabsorbable Stents Market Outlook
5.1. Key Highlights
5.1.1. Market Volume (Units) Projections
5.1.2. Market Size (Us$ Bn) And Y-o-y Growth
5.1.3. Absolute $ Opportunity
5.2. Market Size (Us$ Bn) And Volume (Units) Analysis And Forecast
5.2.1. Historical Market Size (Us$ Bn) Analysis, 2019-2024
5.2.2. Market Size (Us$ Bn) Analysis And Forecast, 2025-2032
5.3. Global Bioabsorbable Stents Market Outlook: Material Type
5.3.1. Introduction / Key Findings
5.3.2. Historical Market Size (Us$ Bn) And Volume (Units) Analysis, By Material Type, 2019 - 2024
5.3.3. Market Size (Us$ Bn) And Volume (Units) Analysis And Forecast, By Material Type, 2025-2032
5.3.3.1. Polymer-based Bioabsorbable Stents
5.3.3.2. Metal-based Bioabsorbable Stents
5.3.3.2.1. Magnesium Alloy
5.3.3.2.2. Zinc Alloy
5.3.3.2.3. Iron-based
5.3.4. Market Attractiveness Analysis: Material Type
5.4. Global Bioabsorbable Stents Market Outlook: Product Type
5.4.1. Introduction / Key Findings
5.4.2. Historical Market Size (Us$ Bn) Analysis, By Product Type, 2019 - 2024
5.4.3. Market Size (Us$ Bn) Analysis And Forecast, By Product Type, 2025-2032
5.4.3.1. Drug-eluting Bioabsorbable Stents
5.4.3.2. Bare Bioabsorbable Stents
5.4.4. Market Attractiveness Analysis: Product Type
5.5. Global Bioabsorbable Stents Market Outlook: Application
5.5.1. Introduction / Key Findings
5.5.2. Historical Market Size (Us$ Bn) Analysis, By Application, 2019 - 2024
5.5.3. Market Size (Us$ Bn) Analysis And Forecast, By Application, 2025-2032
5.5.3.1. Coronary Artery Disease (Cad)
5.5.3.2. Peripheral Artery Disease (Pad)
5.5.4. Market Attractiveness Analysis: Application
5.6. Global Bioabsorbable Stents Market Outlook: End-user
5.6.1. Introduction / Key Findings
5.6.2. Historical Market Size (Us$ Bn) Analysis, By End-user, 2019 - 2024
5.6.3. Market Size (Us$ Bn) Analysis And Forecast, By End-user, 2025-2032
5.6.3.1. Hospitals
5.6.3.2. Cardiology Centers
5.6.3.3. Ambulatory Surgical Centers (Ascs)
5.6.3.4. Specialty Clinics
5.6.4. Market Attractiveness Analysis: End-user
6. Global Bioabsorbable Stents Market Outlook: Region
6.1. Key Highlights
6.2. Historical Market Size (Us$ Bn) And Volume (Units) Analysis, By Region, 2019 - 2024
6.3. Market Size (Us$ Bn) And Volume (Units) Analysis And Forecast, By Region, 2025-2032
6.3.1. North America
6.3.2. Europe
6.3.3. East Asia
6.3.4. South Asia And Oceania
6.3.5. Latin America
6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region
7. North America Bioabsorbable Stents Market Outlook
7.1. Key Highlights
7.2. Historical Market Size (Us$ Bn) Analysis, By Market, 2019 - 2024
7.2.1. By Country
7.2.2. By Material Type
7.2.3. By Product Type
7.2.4. By Application
7.2.5. By End-user
7.3. Market Size (Us$ Bn) Analysis And Forecast, By Country, 2025-2032
7.3.1. U.S.
7.3.2. Canada
7.4. Market Size (Us$ Bn) And Volume (Units) Analysis And Forecast, By Material Type, 2025-2032
7.4.1. Polymer-based Bioabsorbable Stents
7.4.2. Metal-based Bioabsorbable Stents
7.4.2.1. Magnesium Alloy
7.4.2.2. Zinc Alloy
7.4.2.3. Iron-based
7.5. Market Size (Us$ Bn) Analysis And Forecast, By Product Type, 2025-2032
7.5.1. Drug-eluting Bioabsorbable Stents
7.5.2. Bare Bioabsorbable Stents
7.6. Market Size (Us$ Bn) Analysis And Forecast, By Application, 2025-2032
7.6.1. Coronary Artery Disease (Cad)
7.6.2. Peripheral Artery Disease (Pad)
7.7. Market Size (Us$ Bn) Analysis And Forecast, By End-user, 2025-2032
7.7.1. Hospitals
7.7.2. Cardiology Centers
7.7.3. Ambulatory Surgical Centers (Ascs)
7.7.4. Specialty Clinics
7.8. Market Attractiveness Analysis
8. Europe Bioabsorbable Stents Market Outlook
8.1. Key Highlights
8.2. Historical Market Size (Us$ Bn) Analysis, By Market, 2019 - 2024
8.2.1. By Country
8.2.2. By Material Type
8.2.3. By Product Type
8.2.4. By Application
8.2.5. By End-user
8.3. Market Size (Us$ Bn) Analysis And Forecast, By Country, 2025-2032
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Russia
8.3.7. Turkey
8.3.8. Rest Of Europe
8.4. Market Size (Us$ Bn) And Volume (Units) Analysis And Forecast, By Material Type, 2025-2032
8.4.1. Polymer-based Bioabsorbable Stents
8.4.2. Metal-based Bioabsorbable Stents
8.4.2.1. Magnesium Alloy
8.4.2.2. Zinc Alloy
8.4.2.3. Iron-based
8.5. Market Size (Us$ Bn) Analysis And Forecast, By Product Type, 2025-2032
8.5.1. Drug-eluting Bioabsorbable Stents
8.5.2. Bare Bioabsorbable Stents
8.6. Market Size (Us$ Bn) Analysis And Forecast, By Application, 2025-2032
8.6.1. Coronary Artery Disease (Cad)
8.6.2. Peripheral Artery Disease (Pad)
8.7. Market Size (Us$ Bn) Analysis And Forecast, By End-user, 2025-2032
8.7.1. Hospitals
8.7.2. Cardiology Centers
8.7.3. Ambulatory Surgical Centers (Ascs)
8.7.4. Specialty Clinics
8.8. Market Attractiveness Analysis
9. East Asia Bioabsorbable Stents Market Outlook
9.1. Key Highlights
9.2. Historical Market Size (Us$ Bn) Analysis, By Market, 2019 - 2024
9.2.1. By Country
9.2.2. By Material Type
9.2.3. By Product Type
9.2.4. By Application
9.2.5. By End-user
9.3. Market Size (Us$ Bn) Analysis And Forecast, By Country, 2025-2032
9.3.1. China
9.3.2. Japan
9.3.3. South Korea
9.4. Market Size (Us$ Bn) And Volume (Units) Analysis And Forecast, By Material Type, 2025-2032
9.4.1. Polymer-based Bioabsorbable Stents
9.4.2. Metal-based Bioabsorbable Stents
9.4.2.1. Magnesium Alloy
9.4.2.2. Zinc Alloy
9.4.2.3. Iron-based
9.5. Market Size (Us$ Bn) Analysis And Forecast, By Product Type, 2025-2032
9.5.1. Drug-eluting Bioabsorbable Stents
9.5.2. Bare Bioabsorbable Stents
9.6. Market Size (Us$ Bn) Analysis And Forecast, By Application, 2025-2032
9.6.1. Coronary Artery Disease (Cad)
9.6.2. Peripheral Artery Disease (Pad)
9.7. Market Size (Us$ Bn) Analysis And Forecast, By End-user, 2025-2032
9.7.1. Hospitals
9.7.2. Cardiology Centers
9.7.3. Ambulatory Surgical Centers (Ascs)
9.7.4. Specialty Clinics
9.8. Market Attractiveness Analysis
10. South Asia & Oceania Bioabsorbable Stents Market Outlook
10.1. Key Highlights
10.2. Historical Market Size (Us$ Bn) Analysis, By Market, 2019 - 2024
10.2.1. By Country
10.2.2. By Material Type
10.2.3. By Product Type
10.2.4. By Application
10.2.5. By End-user
10.3. Market Size (Us$ Bn) Analysis And Forecast, By Country, 2025-2032
10.3.1. India
10.3.2. Southeast Asia
10.3.3. Anz
10.3.4. Rest Of South Asia & Oceania
10.4. Market Size (Us$ Bn) And Volume (Units) Analysis And Forecast, By Material Type, 2025-2032
10.4.1. Polymer-based Bioabsorbable Stents
10.4.2. Metal-based Bioabsorbable Stents
10.4.2.1. Magnesium Alloy
10.4.2.2. Zinc Alloy
10.4.2.3. Iron-based
10.5. Market Size (Us$ Bn) Analysis And Forecast, By Product Type, 2025-2032
10.5.1. Drug-eluting Bioabsorbable Stents
10.5.2. Bare Bioabsorbable Stents
10.6. Market Size (Us$ Bn) Analysis And Forecast, By Application, 2025-2032
10.6.1. Coronary Artery Disease (Cad)
10.6.2. Peripheral Artery Disease (Pad)
10.7. Market Size (Us$ Bn) Analysis And Forecast, By End-user, 2025-2032
10.7.1. Hospitals
10.7.2. Cardiology Centers
10.7.3. Ambulatory Surgical Centers (Ascs)
10.7.4. Specialty Clinics
10.8. Market Attractiveness Analysis
11. Latin America Bioabsorbable Stents Market Outlook
11.1. Key Highlights
11.2. Historical Market Size (Us$ Bn) Analysis, By Market, 2019 - 2024
11.2.1. By Country
11.2.2. By Material Type
11.2.3. By Product Type
11.2.4. By Application
11.2.5. By End-user
11.3. Market Size (Us$ Bn) Analysis And Forecast, By Country, 2025-2032
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest Of Latin America
11.4. Market Size (Us$ Bn) And Volume (Units) Analysis And Forecast, By Material Type, 2025-2032
11.4.1. Polymer-based Bioabsorbable Stents
11.4.2. Metal-based Bioabsorbable Stents
11.4.2.1. Magnesium Alloy
11.4.2.2. Zinc Alloy
11.4.2.3. Iron-based
11.5. Market Size (Us$ Bn) Analysis And Forecast, By Product Type, 2025-2032
11.5.1. Drug-eluting Bioabsorbable Stents
11.5.2. Bare Bioabsorbable Stents
11.6. Market Size (Us$ Bn) Analysis And Forecast, By Application, 2025-2032
11.6.1. Coronary Artery Disease (Cad)
11.6.2. Peripheral Artery Disease (Pad)
11.7. Market Size (Us$ Bn) Analysis And Forecast, By End-user, 2025-2032
11.7.1. Hospitals
11.7.2. Cardiology Centers
11.7.3. Ambulatory Surgical Centers (Ascs)
11.7.4. Specialty Clinics
11.8. Market Attractiveness Analysis
12. Middle East & Africa Bioabsorbable Stents Market Outlook
12.1. Key Highlights
12.2. Historical Market Size (Us$ Bn) Analysis, By Market, 2019 - 2024
12.2.1. By Country
12.2.2. By Material Type
12.2.3. By Product Type
12.2.4. By Application
12.2.5. By End-user
12.3. Market Size (Us$ Bn) Analysis And Forecast, By Country, 2025-2032
12.3.1. Gcc Countries
12.3.2. Egypt
12.3.3. South Africa
12.3.4. Northern Africa
12.3.5. Rest Of Middle East & Africa
12.4. Market Size (Us$ Bn) And Volume (Units) Analysis And Forecast, By Material Type, 2025-2032
12.4.1. Polymer-based Bioabsorbable Stents
12.4.2. Metal-based Bioabsorbable Stents
12.4.2.1. Magnesium Alloy
12.4.2.2. Zinc Alloy
12.4.2.3. Iron-based
12.5. Market Size (Us$ Bn) Analysis And Forecast, By Product Type, 2025-2032
12.5.1. Drug-eluting Bioabsorbable Stents
12.5.2. Bare Bioabsorbable Stents
12.6. Market Size (Us$ Bn) Analysis And Forecast, By Application, 2025-2032
12.6.1. Coronary Artery Disease (Cad)
12.6.2. Peripheral Artery Disease (Pad)
12.7. Market Size (Us$ Bn) Analysis And Forecast, By End-user, 2025-2032
12.7.1. Hospitals
12.7.2. Cardiology Centers
12.7.3. Ambulatory Surgical Centers (Ascs)
12.7.4. Specialty Clinics
12.8. Market Attractiveness Analysis
13. Competition Landscape
13.1. Market Share Analysis, 2024
13.2. Market Structure
13.2.1. Competition Intensity Mapping By Market
13.2.2. Competition Dashboard
13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
13.3.1. Biotronik Se & Co. Kg
13.3.1.1. Overview
13.3.1.2. Segments And Components
13.3.1.3. Key Financials
13.3.1.4. Market Developments
13.3.1.5. Market Strategy
13.3.2. Elixir Medical Corporation
13.3.3. Abbott Laboratories
13.3.4. Reva Medical, Llc
13.3.5. Arterius Ltd.
13.3.6. Boston Scientific Corporation
13.3.7. Lepu Medical Technology Co., Ltd.
13.3.8. Terumo Corporation
13.3.9. Amaranth Medical
13.3.10. S3v Vascular Technologies
13.3.11. Kyoto Medical Planning Co., Ltd.
13.3.12. Microport Scientific Corporation
13.3.13. Zorion Medical
13.3.14. Smt (Sahajanand Medical Technologies)
13.3.15. Hexacath
13.3.16. Cardionovum Gmbh
13.3.17. B. Braun Melsungen Ag
14. Appendix
14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms And Abbreviations
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.